AGP Executive Report

Psychosis Care in Switzerland: The International Society for Psychological and Social Approaches to Psychosis (ISPS) marked its 70th anniversary in Lausanne, tracing how Swiss-founded, non-reductionist approaches have grown into a broader, more multidisciplinary push for accessible talking therapies. Swiss Pharma Watch: Roche reaffirmed its 2026 outlook after first-half sales dipped in Swiss-franc terms, with currency strength and weaker U.S. demand for Vabysmo cited; the company points to later-year launches including Itovebi and new breast-cancer data. Metabolism at Home (Swiss tech): ETH Zurich researchers showcased a smartphone-assisted breath test that detects acetone in exhaled breath to track fat burning, aiming to support personalized care for obesity, diabetes, and related metabolic conditions. Health & Safety Policy: In Pennsylvania, ICE dropped plans to use two warehouses as detention centers after DHS withdrew appeals tied to water and sewage requirements—officials cited health, safety, and infrastructure risks. Public Health & Environment: Experts warned that relief from heat and wildfire smoke is likely temporary, with smoke episodes driven by weather patterns that trap pollutants close to the ground. Regulation & Consumer Safety: A U.S. court permanently banned 19 online sellers of fake Urolithin A supplements, backing Timeline/Amazentis’ claims of misleading marketing.

Ebola Response: Switzerland boosts Ebola support for the DRC with an extra CHF 1.6 million to WHO, bringing total Swiss aid to CHF 4.6 million, aimed at strengthening emergency medical team coordination and expanding testing capacity. Medtech Finance: Healthcare Holding Schweiz AG secures CHF 80 million in syndicated financing to fund further acquisitions and growth as Switzerland’s large independent medtech distributor. Diagnostics Watch: Roche Diagnostics reports muted growth (up 3% in sales at constant exchange rates for H1) as China pricing reforms continue to pressure device and near-patient care revenue. Swiss Pharma Deals: Samsung Biologics makes an all-cash ~$1.8 billion tender offer to buy Switzerland-based PolyPeptide, expanding into peptide therapeutics for areas like obesity and diabetes. Public Health & Climate: Swiss experts warn drought may reduce tick activity and affect Japanese beetle larvae, with limited data but clear links to tick-borne disease trends. Health Systems Insight: Korea’s longevity stands out despite a severe physician shortage, highlighting how prevention and access can offset workforce strain. Workforce & Policy: Spain nominates Labour Minister Yolanda Díaz to lead the UN’s ILO in Geneva as the agency faces financial pressure tied to US non-payments.

Swiss Health Tech: ETH Zurich researchers unveiled a portable breath device that detects acetone to track fat burning at home, potentially helping tailor diets and metabolic therapies. Global HIV Funding: UNAIDS chief Winnie Byanyima warned that major donor cuts are straining HIV programs and urged African governments to boost domestic health spending. MS Immunology: New research suggests B-cell depletion in multiple sclerosis may work partly by recruiting protective, gut-derived regulatory B cells into the blood and brain to calm neuroinflammation. Public Health & Heat: France reported 5,764 excess deaths during a June 17–July 2 heat wave, with the biggest toll among people over 75. Policy & Medicines: Trump’s proposed tariffs on imported generic drugs could raise costs for patients; experts say tariffs alone may not drive onshoring. Switzerland-linked Business: Lonza posted strong first-half results, with higher core EBITDA and margin expansion. Geneva & Environment: UNITAR ran its inaugural UN chemicals and waste management study programme in Geneva, focusing on safer chemicals governance and circular economy skills. Care Access in Switzerland: Sjögren Europe launched its “Nobody Listens” campaign ahead of World Sjögren’s Day, pushing for earlier diagnosis and better recognition of invisible symptoms.

Zurich Drug Crackdown: Zurich says visible drug use and dealing have surged in summer hotspots around Bäckeranlage and the main station, and it’s ramping up police and social workers, identity checks and dispersal orders, with people directed to designated consumption sites. Gene Editing Funding (Zurich): Immitra Bio, a Zürich-based in-vivo gene editing platform, raised €2.58m pre-Seed to scale its mutation-agnostic therapies and digital target identification work. Mental Health Science (Switzerland-linked): A Brown University-led study published in Nature Mental Health links serotonin to improved cognitive flexibility and reduced “belief stickiness,” offering new angles for OCD treatment; collaborators include the University of Zurich and ETH Zurich. EV Battery Warranty (Switzerland): Aviloo’s data-based battery health warranty expands across Europe, including Switzerland, using a three-minute diagnostic test and compensation if capacity drops below a set threshold. Public Health & Access (Geneva): Geneva’s provisional suspension of its burkini ban keeps full-body swimwear allowed in pools for now, citing potential fundamental-rights concerns during the summer season. Drug Prices & Trade (Swiss industry impact): Reports say the EU is pushing back on US generic drug tariff threats, while Trump proposes 100% tariffs on generics from 2028—an issue that could ripple into Swiss generics suppliers.

Drug Policy & Supply Chains: Trump says generic drug makers will face a 100% US import duty from August 2028 if they don’t shift production to the US within two years, with the rate doubling in 2029—aimed at reshoring cheaper medicines. Public Health & Vaccines: India approved its first dengue vaccine, Qdenga (for ages 4–60), with two doses three months apart, marking a major step in mosquito-borne disease prevention. Cancer Care Investment: Novartis plans about $95m in Korea to build a radioligand therapy ecosystem, including manufacturing and expanding hospital access. Medical Humanitarian Pressure: MSF in Geneva urged Israel to release detained Palestinian healthcare workers, citing solitary confinement and alleged torture of Dr. Hussam Abu Safia and calling for action on dozens of imprisoned staff. Tech for Health Monitoring: Swiss company Aktiia launched Hilo Core in the US, a screen-free wrist band with optical blood pressure monitoring plus a monthly wireless calibration cuff. Influenza Research: Scientists mapped how influenza A hijacks human cells to replicate, pointing to new directions for antivirals and vaccines.

Swiss Pharma Watch: Novartis reported higher-than-expected Q2 core operating income, with newer medicines helping offset Entresto’s slide as generics bite, and it kept its 2026 outlook. Cancer Tech & IP: The European Patent Office upheld patent protection for SOTIO’s PD-1 immunocytokine SOT201, strengthening its IP position for early-stage cancer work. Cardiology Devices: Vesalio’s randomized NATURE trial of its enVast coronary thrombectomy system was selected for a late-breaking presentation at the ESC Congress in Munich. Biotech Deals: Lonza and Engitix signed a licensing agreement to advance ADC development, while Immitra raised CHF 2.4M to push in-vivo gene editing toward an inherited anemia approach. Public Health & Prevention: India approved its first dengue vaccine, Qdenga, for ages 4–60, marking a major step in dengue prevention. Environment & Health Risks (Switzerland): A Swiss study links rising calima dust events to climate change, and separate reporting says Japanese beetles are spreading to more Swiss regions—prompting new local control measures. Wellness in Zurich: Swissline opened the renovated Labo Spa flagship in Zurich, positioning it as “Swiss” skincare plus hospitality.

Zurich Wellness & Skincare: Swissline opened a renovated urban wellness destination, LaboSpa, in Zurich—another sign of Switzerland’s appetite for accessible, lifestyle-focused self-care. Public Health & Safety: Swiss churches protested a new Military Law change that abolishes traditional military service exemptions for clergy, raising concerns about how policy shifts could affect healthcare and community support roles. Child Wellbeing & Outdoor Play: Swiss research is being cited in debate over children’s independence—suggesting that simply removing phones won’t help unless kids can safely play outside near home. Medicine Integrity: WHO warned Pakistan’s regulator about fake blood cancer medicines, with Swiss-linked packaging mentioned—highlighting ongoing cross-border risks in pharma supply chains. Humanitarian Aid: Switzerland pledged $2.4m to UNHCR for Afghanistan, aimed at reintegration and support for vulnerable communities amid severe needs. AI for Precision Medicine: A Horizon Europe-funded project (AIRIS) is set to use generative AI to build more personalized, mechanism-informed biomedical models.

Drug policy in Zurich: A city-run crack cocaine consumption room model is being tested by a surge in use, with four centres operating up to 13 hours a day and staff-led harm-reduction support. Antibiotics update: Temocillin—an older antibiotic—shows non-inferior performance versus carbapenems for certain resistant bloodstream infections, with safety profiles broadly similar. Eye health R&D: Belite Bio reported additional positive Phase 3 secondary results for tinlarebant in Stargardt disease type 1, including quantitative autofluorescence divergence vs placebo. Cancer immunotherapy: Nouscom’s NOUS-209 Lynch syndrome data were accepted for an ESMO oral presentation, covering re-treatment safety and longer follow-up. Air quality & climate: Swiss research links climate change and more frequent heatwaves to rising ground-level ozone, which irritates the respiratory tract even as some emissions improve. Food safety rules: SGS released guidance on new EU listeria requirements for ready-to-eat foods starting July 1, 2026. Healthcare industry moves (Switzerland): Samsung Biologics agreed to buy PolyPeptide (Baar) in a deal aimed at expanding peptide drug manufacturing capacity.

Air Quality & Wildfire Health: Toronto’s wildfire smoke warning was lifted after days of orange-to-yellow alerts, with officials flagging a possible dip to “moderate risk” later—an important reminder for people with asthma or heart conditions to plan around AQHI changes. Public Health Research: A new study in Cell reports that severe COVID-19 patients may fail to control the virus because their immune systems produce B cells that target and neutralize type I interferons, weakening an early antiviral defense. Healthcare Policy & End-of-Life Debate: Taiwan’s opposition is pushing a “nine-in-one” referendum that would legalize euthanasia under regulated patient autonomy rules, as the country grapples with aging and long-term care pressures. Swiss Health & Care Infrastructure: A new autism clinic has opened in Lake Zurich, expanding local access to specialized support. Biotech & Pharma (Switzerland-linked): Samsung Biologics announced an all-cash tender offer to acquire PolyPeptide, a peptide CDMO, aiming to strengthen global manufacturing capacity for advanced therapies.

Air Quality & Climate: A new study led by Switzerland’s Paul Scherrer Institute finds Saharan dust “calima” is hitting the Canary Islands on about 146 days a year, with dust rising 10–25% over the past decade despite cleaner emissions—an important health warning for southern Europe. Nutrition & Aging: A Swiss-published analysis links regular berry intake (blueberries, strawberries, raspberries and more) with a lower risk of frailty in adults 65+, with the strongest association seen around 37–74 grams per day. Infectious Disease Response: Authorities worldwide are tracing passengers after a hantavirus outbreak on the MV Hondius off Cape Verde, including a Swiss citizen among suspected cases, as officials try to prevent further spread. Public Safety (Switzerland): A 45-year-old Dutch man was arrested after stabbing a 29-year-old on a Basel train platform and chasing him; the victim was taken to hospital and investigators seek witnesses. Health & Wellness Tech: Emora Health is trending among travel wellness seekers, reflecting growing demand for on-the-go wellbeing tools. Sports Medicine Angle (World Cup): FIFA’s technical study group says expanding the World Cup to 48 teams was a success, noting fewer medical interventions and faster goal kicks—signals that rule changes may be improving match flow.

Air Quality & Heat: Wildfire smoke and extreme summer weather are still hitting the US, with millions told to stay indoors and Detroit ranking among the worst for pollution as conditions slowly improve. Public Health Access: Novo Nordisk is launching Extensior, a lower-cost authorised semaglutide copy in South Africa, aiming to expand access after court action against unregistered compounded versions. Swiss Research & Health Tech: ETH Zurich and EPFL researchers unveiled PLATON, an AI-assisted particle detector that could also inspire future medical imaging systems like PET scanners. Prisoner Health in Geneva: Swiss-based Polisario representatives urged the ICRC and UN special rapporteurs to intervene urgently for Sahrawi prisoner Naâma Asfari, citing a prolonged hunger strike and deteriorating health. Wellbeing & Loneliness: A University of Zurich study links personality shifts over time with later loneliness, suggesting loneliness can also feed back into personality traits. Swiss Cities in Global Rankings: Zurich and Geneva both appear in the top tier of the world’s most livable cities list, alongside Zurich’s neighbour Geneva.

Wildfire smoke & air quality: Detroit’s air improved from “hazardous” levels (AQI 724) to “moderate” (AQI 61) but parts of southeast Michigan stayed unhealthy for sensitive groups, keeping the city among the worst in the US and globally. Air-health alerts: Washington, DC was placed under a Code Purple alert as Canadian smoke drifted in, with officials urging people—especially children and those with asthma or heart/lung disease—to stay indoors and limit activity. Legal/health rights: Switzerland lost an ECHR case over vegan meals in prison, with the court saying detainees whose veganism is a protected belief must receive a fully vegan diet throughout detention. Public health & wellness research (Switzerland): A University of Zurich study found young people most often cite positive everyday milestones—school, apprenticeships, friendships, first relationships—as key life events, not just crises. Sports & health policy: Swiss UFC fighter Volkan Oezdemir received a 16-month suspension after admitting EPO use following a healthcare professional’s advice. Community & wellbeing: A Zurich competition saw a vegan jiu-jitsu black belt win two categories at the ADCC Switzerland Open.

Amazon Indigenous knowledge: A University of Zurich-led study warns that climate change and disappearing languages could wipe out about a quarter of Amazon plant know-how, with communities using nearly 5,800 native species for food and medicine. End-of-life law watch (France): France’s National Assembly has given final approval to assisted dying/euthanasia legislation, now headed to the Constitutional Council after a long, contentious parliamentary fight. Swiss food safety: Solothurn found pesticide residues above legal limits in 32% of tested Asian supermarket vegetable samples, triggering a criminal complaint in one case. Wildfire smoke health: Hazardous air hit parts of the US Midwest and East as Canadian smoke drifted south, with Detroit among the worst major cities on IQAir readings. Swiss healthcare innovation: MindMaze Therapeutics opened a US headquarters in Charlotte, focusing on neuro-recovery tech for stroke, Alzheimer’s and Parkinson’s. Sports doping (Swiss athlete): UFC contender Volkan Oezdemir says he used banned EPO and received a 16-month suspension.

Heat & health impact: AFP reports at least 12,000 excess deaths across nine European countries during late-June heat, with Switzerland among the hardest hit and figures expected to rise as more data comes in. Swiss rights & healthcare access: Switzerland was convicted by the European Court of Human Rights for failing to provide fully vegan meals to two detainees, ruling it breached freedom of thought and conscience. Air quality warning (not Switzerland, but relevant for readers): Environment Canada kept an orange-level air alert for the Greater Toronto Area as wildfire smoke continues to drive very poor PM2.5 levels, with health risks for everyone. Dental tech in Switzerland: Researchers at the University of Basel are developing MIR, a tiny intraoral robot aimed at preparing teeth for crowns and potentially reducing the number of visits. Public health & prevention: A guide on surviving heatwave skin issues recommends lighter moisturisers, protecting the skin barrier, and adjusting routines to avoid breakouts. Local Swiss health-adjacent news: Swiss customs fined a driver for trying to import 40 bee colonies without the required licence. WHO opportunity: WHO opened its Global Internship Programme to citizens of all 194 member states, with placements in Switzerland and worldwide.

Heat & Mortality: An AFP analysis links Europe’s late-June heatwave to at least 12,000 excess deaths across nine countries, with record temperatures reported including in Switzerland, and warns the toll could rise as more data comes in. Air Quality Crisis: Wildfire smoke from Canada is driving hazardous air across North America; Detroit was ranked the world’s most polluted major city at one point, while Chicago-area agencies reported very unhealthy to hazardous PM2.5 levels, prompting closures and indoor-only guidance. Local Health Access: A new autism therapy clinic opened in Lake Zurich, offering diagnostic evaluation and Applied Behavior Analysis with family support. Cancer Research (Switzerland): Dosing resumed in a Swiss site for INT230-6 in a phase 2 neoadjuvant TNBC trial (INVINCIBLE-4/SAKK 66/22) after a pause tied to skin irritation concerns. Alzheimer’s (Swiss pharma): Roche plans the PrevenTRON study to test its anti-amyloid trontinemab in earlier Alzheimer’s stages, using its TRAVELLER registry to speed screening. Policy Watch: France approved an assisted-dying bill with strict safeguards, moving it to a constitutional review step. Trade & Health Economy: New Zealand and Switzerland agreed to start trade talks, with Swiss exports including pharmaceuticals and medical products.

Assisted Dying in France: France’s National Assembly has given final approval to a right-to-die law for adults with incurable, life-threatening conditions, with eligibility checks, a collegial review, and safeguards; the text still needs review by France’s Constitutional Council before it can take effect (potentially early 2027). Swiss Legal Rights: The European Court of Human Rights partially upheld a complaint by two Swiss vegans, finding Switzerland violated their freedom of conscience after they were not consistently given vegan meals in detention settings. Air Quality & Health: Wildfire smoke has pushed Toronto’s air to “very high risk” levels (AQHI 10+), with health agencies urging people to limit time outdoors and use well-fitted masks like N95. Mental Health (Switzerland-linked): Switzerland is funding a Nepal–UN mental health support programme (2025–2028) to expand access to psychosocial care and strengthen services across provinces. Primary Care Debate (Switzerland): At WONCA Europe 2026, Lausanne family physician Nicolas Sen argued for interprofessional primary care teams, while others defended the central role of the general practitioner. Ebola Watch: WHO reports the DRC Ebola outbreak is the fastest-growing on record, with many new cases coming from unknown transmission chains.